International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 2783-2787
Research Article
A Retrospective Study of Surgical Site Infections and Associated Risk Factors in General Surgery
 ,
 ,
Received
May 2, 2026
Accepted
May 24, 2026
Published
June 10, 2026
Abstract

Background: Surgical site infections (SSIs) are among the most common postoperative complications and contribute significantly to morbidity, prolonged hospital stays, and increased healthcare costs.

Objective: To determine the incidence of surgical site infections and to identify the associated risk factors in patients undergoing general surgical procedures.

Materials and Methods: This retrospective observational analytical study was conducted in the Department of General Surgery of a tertiary care hospital. Data were collected from medical records of patients who underwent surgical procedures between January 2025 and December 2025. A total of 200 patients were included. Patient demographics, comorbidities, type and duration of surgery, wound classification, and perioperative factors were analyzed. Surgical site infections were identified based on standard criteria. Statistical analysis was performed using Chi-square test for categorical variables and Student’s t-test for continuous variables, with p < 0.05 considered statistically significant.

Results: The overall incidence of SSI was 15%. Higher infection rates were observed in patients with diabetes mellitus, contaminated and dirty wounds, prolonged surgical duration (>2 hours), and emergency procedures, all showing statistically significant association (p < 0.05). Patients with SSI had a significantly longer hospital stay compared to those without infection (p < 0.001).

Conclusion: Surgical site infections remain a significant concern in general surgery. Identification and modification of risk factors such as diabetes, wound contamination, and operative duration can help reduce SSI incidence and improve patient outcomes.

Keywords
INTRODUCTION

Surgical site infections (SSIs) are among the most common healthcare-associated infections and represent a significant cause of postoperative morbidity and mortality worldwide. According to the World Health Organization, SSIs account for a substantial proportion of all hospital-acquired infections, particularly in low- and middle-income countries where the burden is considerably higher due to resource limitations and variability in infection control practices (1).

 

SSIs are defined as infections occurring within 30 days after a surgical procedure or within one year in cases involving prosthetic implants, affecting either the incision or deep tissues at the operative site. The Centers for Disease Control and Prevention classifies SSIs into superficial incisional, deep incisional, and organ/space infections, each with varying clinical severity and outcomes (2). These infections not only prolong hospital stay but also increase healthcare costs, readmission rates, and the need for additional surgical interventions.

 

The incidence of SSIs varies widely across different regions and healthcare settings, ranging from 2% to 20% depending on the type of surgery and patient population. Higher rates are consistently reported in developing countries, where factors such as inadequate sterilization techniques, overcrowding, and limited surveillance systems contribute to increased infection rates (3). SSIs are associated with significant economic burden, including increased antibiotic usage and longer hospitalization, thereby straining already limited healthcare resources (6).

 

The pathogenesis of SSIs is multifactorial, involving a complex interaction between microbial contamination, host immunity, and surgical factors. Common causative organisms include Staphylococcus aureus, Escherichia coli, and other gram-negative bacilli. Patient-related risk factors such as advanced age, diabetes mellitus, obesity, malnutrition, and immunosuppression play a critical role in susceptibility to infection. Procedure-related factors such as duration of surgery, wound classification, surgical technique, and perioperative antibiotic prophylaxis also significantly influence the risk of SSI (4,5).

 

Wound classification remains an important determinant of SSI risk, with clean wounds having the lowest risk and contaminated or dirty wounds demonstrating significantly higher infection rates. Prolonged surgical duration increases exposure to environmental pathogens and tissue trauma, thereby facilitating microbial colonization. Emergency surgeries are also associated with higher SSI rates due to inadequate preoperative preparation and optimization of patient condition.

Despite advancements in surgical techniques, sterilization methods, and antibiotic prophylaxis, SSIs continue to be a major challenge in modern surgical practice. Continuous surveillance and identification of modifiable risk factors are essential for implementing targeted preventive strategies. Retrospective studies provide valuable insights into real-world clinical settings, enabling evaluation of trends, risk factors, and outcomes associated with SSIs.

 

Therefore, the present study was undertaken to assess the incidence of surgical site infections and to identify associated risk factors in patients undergoing general surgical procedures in a tertiary care setting.

 

MATERIALS AND METHODS:

Study Design

This study was a retrospective observational analytical study conducted to evaluate the incidence of surgical site infections (SSIs) and associated risk factors among patients undergoing general surgical procedures.

 

Study Setting

The study was carried out in the Department of General Surgery of a tertiary care teaching hospital, which caters to a large population and performs a wide range of elective and emergency surgical procedures.

 

Study Period

Data were collected retrospectively from hospital records over a period of one year, from January 2025 to December 2025.

 

Study Population

The study population included all patients who underwent surgical procedures in the Department of General Surgery during the study period.

 

Sample Size

A total of 200 patients who fulfilled the inclusion criteria were included in the study. The sample size was based on the availability of complete medical records during the study period.

 

Inclusion Criteria

  • Patients undergoing elective and emergency general surgical procedures
  • Patients of all age groups and both genders
  • Patients with complete medical and follow-up records up to 30 days postoperatively

 

Exclusion Criteria

  • Patients with incomplete or missing medical records
  • Patients lost to follow-up within 30 days after surgery
  • Patients with pre-existing infections at the surgical site

 

Definition of Surgical Site Infection

Surgical site infections were defined according to the criteria laid down by the Centers for Disease Control and Prevention as infections occurring within 30 days after surgery involving the incision or deep tissues at the operative site.

SSIs were classified into:

  • Superficial incisional SSI
  • Deep incisional SSI
  • Organ/space SSI

Data Collection

Data were retrieved from:

  • Medical records
  • Operation theatre registers
  • Infection control surveillance records

 

Data Management

Data were entered into Microsoft Excel and analyzed using SPSS version 20.0. Continuous variables were expressed as mean ± standard deviation, and categorical variables as frequencies and percentages.

The Chi-square test was used to assess associations between categorical variables, and the Student’s t-test was applied for comparison of continuous variables. A p-value < 0.05 was considered statistically significant

 

Ethical Considerations

  • Approval was obtained from the Institutional Ethics Committee prior to the study
  • Patient confidentiality was maintained
  • Data were used strictly for research purposes

 

RESULTS:

A total of 200 patients who underwent general surgical procedures during the study period were included in the analysis.

The majority of patients were male (60%), with a mean age of 45 ± 12 years, indicating that middle-aged individuals constituted the predominant study population (Table 1).

 

Table 1: Demographic Characteristics of Study Population

Variable

Category

Value

Age (years)

Mean ± SD

45 ± 12

Gender

Male

120 (60%)

 

Female

80 (40%)

 

The overall incidence of SSI in this study was 15%, indicating that approximately 1 in 7 patients developed postoperative infection (Table 2)

 

Table 2: Incidence of Surgical Site Infection

SSI Status

Number

Percentage

Present

30

15%

Absent

170

85%

 

SSI was significantly higher in contaminated and dirty wounds, demonstrating the strong influence of microbial load and wound environment on infection rates ( Table 3)

 

Table 3: SSI According to Wound Classification

Wound Class

SSI Present

SSI Absent

Total

Clean

2

60

62

Clean-contaminated

5

55

60

Contaminated

12

30

42

Dirty

11

25

36

 

A statistically significant association was observed between SSI and diabetes mellitus, duration of surgery, type of surgery (emergency), and wound contamination (p < 0.05) (Table 4).

 

Table 4: Association of Risk Factors with SSI

Risk Factor

SSI Present

SSI Absent

P-value

Diabetes Mellitus

18

40

<0.05

Non-diabetic

12

130

Surgery > 2 hours

22

50

<0.05

Surgery ≤ 2 hours

8

120

Emergency Surgery

15

45

<0.05

Elective Surgery

15

125

Contaminated/Dirty Wound

23

55

<0.01

Clean/Clean-contaminated

7

115


Patients with SSI had a significantly prolonged hospital stay, reflecting increased morbidity and healthcare burden (Table 5).

 

Table 5: Duration of Hospital Stay

Group

Mean Hospital Stay (days)

P-value

SSI Present

14 ± 4

<0.001

SSI Absent

7 ± 2

 

DISCUSSION:

Surgical site infections (SSIs) continue to be a significant cause of postoperative morbidity despite advances in surgical techniques and infection control practices. In the present study, the overall incidence of SSI was found to be 15%, which is comparable to rates reported in similar studies conducted in developing countries, where SSI incidence ranges between 10% and 20% (7,8). The relatively higher incidence in such settings may be attributed to resource constraints, overcrowding, and variability in adherence to aseptic protocols.

 

In this study, diabetes mellitus was identified as a significant risk factor for SSI. Hyperglycemia impairs leukocyte function, reduces phagocytic activity, and delays wound healing, thereby increasing susceptibility to infection. Similar findings have been reported in previous studies, which demonstrated a strong association between diabetes and postoperative infections (9,10). Effective perioperative glycemic control is therefore essential in reducing SSI rates.

 

Wound classification was another important determinant of SSI in this study. A significantly higher incidence of infection was observed in contaminated and dirty wounds compared to clean wounds. This observation is consistent with established literature, which indicates that infection rates increase proportionally with the degree of microbial contamination (11). The higher bacterial load in contaminated wounds predisposes to infection, especially in the presence of devitalized tissue.

 

The duration of surgery was also found to be significantly associated with SSI. Procedures lasting more than two hours had a higher infection rate compared to shorter procedures. Prolonged operative time increases tissue exposure, risk of contamination, and surgical trauma, all of which contribute to infection development. Similar associations have been reported in multiple studies, emphasizing operative duration as a key modifiable risk factor (12,13).

 

Emergency surgeries were associated with a higher incidence of SSI compared to elective procedures. This may be due to inadequate preoperative preparation, poor patient optimization, and higher likelihood of contaminated surgical fields in emergency settings. Previous studies have similarly reported increased SSI rates in emergency surgeries (14).

 

Another important finding of the present study was the significant increase in hospital stay among patients with SSI. Patients who developed SSI had nearly double the duration of hospitalization compared to those without infection. This finding is consistent with previous reports, which highlight the economic burden of SSIs due to prolonged hospital stay, increased antibiotic use, and additional interventions (15,16).

 

The present study highlights the importance of identifying modifiable risk factors to reduce SSI incidence. Measures such as strict aseptic techniques, appropriate antibiotic prophylaxis, optimal glycemic control, and minimizing operative duration can significantly reduce postoperative infections.

 

However, this study has certain limitations. Being a retrospective study, it is subject to limitations such as incomplete data and potential bias. Additionally, the absence of microbiological analysis and lack of long-term follow-up may limit the comprehensive evaluation of infection patterns.

 

CONCLUSION:

Surgical site infections remain a significant postoperative complication in general surgery. Factors such as diabetes mellitus, contaminated wounds, prolonged surgery, and emergency procedures were significantly associated with increased risk. Early identification and modification of these factors, along with strict aseptic measures and appropriate antibiotic use, can help reduce SSI rates.

 

REFERENCES

  1. World Health Organization. Global guidelines for the prevention of surgical site infection. Geneva: WHO; 2016.
  2. Centers for Disease Control and Prevention. Guideline for prevention of surgical site infection. Atlanta: CDC; 2017.
  3. Benedetta Allegranzi, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic healthcare-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–241.
  4. A.J. Mangram, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20:250–278.
  5. C.D. Owens, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. Surg Clin North Am. 2008;88:567–580.
  6. G. de Lissovoy, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37:387–397.
  7. K. Singh, et al. Surgical site infections: incidence and risk factors in a tertiary care hospital. J Clin Diagn Res. 2015;9:PC01–PC04.
  8. R. Patel, et al. A study of surgical site infections in a tertiary care center. Int J Surg. 2014;12:407–410.
  9. A. Martin, et al. Impact of diabetes on surgical site infections. Ann Surg. 2011;253:345–350.
  10. J. Fry, et al. Diabetes and postoperative infections. Surg Infect. 2013;14:23–29.
  11. C. Cruse, et al. The epidemiology of wound infection. Surg Clin North Am. 1980;60:27–40.
  12. R. Culver, et al. Risk factors for surgical site infections. Am J Med. 1991;91:152–157.
  13. D. Kirkland, et al. Impact of surgical site infections on hospital stay. Infect Control Hosp Epidemiol. 1999;20:725–730.
  14. M. Lilani, et al. Surgical site infection in clean and clean contaminated cases. J Pak Med Assoc. 2005;55:343–346.
  15. G. Whitehouse, et al. Impact of SSI on hospital costs. J Hosp Infect. 2002;51:297–302.
  16. S. Leaper, et al. Surgical site infection: prevention and treatment. Lancet. 2010;376: 127–138.
Recommended Articles
Research Article Open Access
A Computed Tomographic Study of Thoracic Pedicle Morphometry at a Tertiary Care Centre in Eastern India
2026, Volume-7, Issue 3 : 2794-2799
Research Article Open Access
Effectiveness of Ultrasound-Guided Tarsal Tunnel Block in Patients with Chronic Coccydynia: A Prospective Observational Study
2026, Volume-7, Issue 3 : 2788-2793
Research Article Open Access
Comparison Of BISAP and Ranson's Scores in Predicting Severity of Acute Pancreatitis: A Prospective Observational Study
2026, Volume-7, Issue 3 : 2777-2782
Research Article Open Access
Comparative analysis of CBNAAT and Ziehl-Nielsen (ZN) staining test in clinically suspected cases of Tubercular Pleural Effusion
2026, Volume-7, Issue 3 : 2702-2707
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
9 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved